2018
DOI: 10.1016/j.intimp.2018.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Oral engineered Bifidobacterium longum expressing rhMnSOD to suppress experimental colitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
22
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 50 publications
(22 citation statements)
references
References 48 publications
0
22
0
Order By: Relevance
“…Recently, “designer probiotics” has drawn attention as an innovative approach, where genetically engineered bacteria with specific functionalities are administered to patients[ 112 ]. Promising results were found when recombinant Bifidobacteria were used as carriers for alpha-melanocyte and manganese superoxide dismutase in experimental colitis[ 113 , 114 ]. In recent years, “specific targeting” which allows nutrients or bioactive compounds to reach and target the specific site of inflammation to exert their effects, has become a trending topic of research for IBD control and will be of tremendous importance in future research[ 115 ].…”
Section: Future Trendsmentioning
confidence: 99%
“…Recently, “designer probiotics” has drawn attention as an innovative approach, where genetically engineered bacteria with specific functionalities are administered to patients[ 112 ]. Promising results were found when recombinant Bifidobacteria were used as carriers for alpha-melanocyte and manganese superoxide dismutase in experimental colitis[ 113 , 114 ]. In recent years, “specific targeting” which allows nutrients or bioactive compounds to reach and target the specific site of inflammation to exert their effects, has become a trending topic of research for IBD control and will be of tremendous importance in future research[ 115 ].…”
Section: Future Trendsmentioning
confidence: 99%
“…Other studies have focused on modifying bacteria to produce substances that counteract the action of reactive oxygen species (ROS) (Bruno-Bárcena et al, 2004;Han et al, 2006;Carroll et al, 2007;Watterlot et al, 2010;LeBlanc et al, 2011;del Carmen et al, 2014;Liu et al, 2018). Gastrointestinal tract inflammation has been associated with an overactive immune system and the accumulation of ROS.…”
Section: Constitutive Systemsmentioning
confidence: 99%
“…Most studies involving ROS have genetically modified lactic acid bacteria to be used as delivery vehicles for antioxidants, achieving reduced inflammation in different in vitro and in vivo models. However, one study did utilize the more dominant bacterium, B. longum, to express the antioxidant enzyme manganese superoxide dismutase, reducing DSS-induced colitis in mice (Liu et al, 2018).…”
Section: Constitutive Systemsmentioning
confidence: 99%
“…Therapeutic proteins are gaining increased popularity, due to their low toxicity and minimal nonspecific effect, which allow them increased applicability to multiple disease (Choonara et al ., ; Liu et al ., ). Antimicrobial peptides (AMPs) secreted by intestinal immune, epithelial cells and lymphocytes belong to the important effectors of innate immunity compartment, serving as a first line of the defence against pathogens.…”
Section: Introductionmentioning
confidence: 97%